Skip to main content
. 2018 Apr 4;9:621. doi: 10.3389/fimmu.2018.00621

Figure 2.

Figure 2

Changes of lymphocyte numbers after MTX cessation in lymphoproliferative disorder (LPD) patients. Change in lymphocyte counts in regressive and persistent LPD compared with the range in the control group. Kruskal–Wallis test was used for comparing the three groups. Regressive vs. control, P < 0.05; regressive vs. persistent, P < 0.05. *P < 0.05 for comparison with the value at week 0 in each group. MTX, methotrexate.